Bifidumbacterin forte, 50 mln. coe/package 10 pcs

Pharmacotherapeutic group

Medical immunobiological drug – probiotic

ATX code A07FA

Biological properties
The action of the drug is conditioned by high concentration of bifidobacteria (Bifidobacterium bifidum) adsorbed on activated charcoal particles which are antagonists of a wide range of pathogenic (Shigella, Salmonella, Staphylococcus aureus etc.) and conditionally pathogenic bifidobacteria.) and conditionally pathogenic microorganisms (Proteus, Klebsiella, etc.). Microcolonies of sorbed bifidobacteria provide rapid recovery of normal microflora, which, as a natural biosorbent, accumulates a significant amount of foreign or formed in the body toxic substances. Sorbed bifidobacteria activate regenerative processes in mucous membranes, wall-to-wall digestion, synthesis of vitamins and amino acids, enhance immune defense.

Indications

Active ingredient

Composition

Active substance – bifidobacteria sorbed on activated charcoal particles – at least 50 million colony forming units (5×107 CFU),
supplement – lactose monohydrate – up to 0.85 g.

How to take, the dosage

The drug is used from birth (including premature babies), adults of all age groups.

Depending on the severity of the disease Bifidumbacterin forte® is used in regular or increased doses.

Bifidumbacterin forte® for therapeutic purposes in normal doses:

Course of treatment for acute intestinal infections and food toxic infections 5-

7 days, with other diseases 15-21 days (determined by the nature and severity of the disease). If necessary, the course of treatment may be repeated 2-3 times, each course is carried out one month after the end of the previous course of treatment.

Patients with surgical pathology – for 3-5 days before surgery and for 10-15 days after surgery:

Bifidumbacterin forte® with therapeutic purposes in increased doses is indicated for children from 1 year and adults.

In acute intestinal infection and acute respiratory viral infection from the first day of the disease:

Course of treatment 1-3 days depending on the severity of the condition.

Infectious mononucleosis:

Interaction

Special Instructions

Synopsis

Contraindications

Side effects

Overdose

Pregnancy use

Similarities